Cite
MLA Citation
Johan A Maertens et al.. “Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.” Lancet, vol. 387, no. 10020, 2016, pp. 760–769. http://access.bl.uk/ark:/81055/vdc_100030783672.0x000004